Pharmalot… Pharmalittle… Good Morning
4 CommentsBy Ed Silverman // February 9th, 2012 // 8:06 am
• Pharma Blog » Archives
Intellectual Property
AstraZeneca & Repurposing Drugs: Morris Explains
2 CommentsBy Ed Silverman // December 8th, 2011 // 6:50 am
Tylenol, False Patent Markings And Due Process
Make a commentBy Ed Silverman // November 16th, 2011 // 9:00 am
Activists Challenge Abbott Over Its AIDS Drug
Make a commentBy Ed Silverman // November 10th, 2011 // 9:39 am
Drugmakers Join UN Project On Tropical Diseases
3 CommentsBy Ed Silverman // October 26th, 2011 // 8:40 am
Access To Meds & Leaked Trade Talk Documents
Make a commentBy Ed Silverman // October 24th, 2011 // 12:12 pm
Former Ambassador Spoke Bluntly About Pharma
6 CommentsBy Ed Silverman // October 6th, 2011 // 9:28 am
Essential Meds, Patents & NCDs: Abbott Explains
Make a commentBy Ed Silverman // September 23rd, 2011 // 9:38 am
A Whitewash? Trade Talks And Access To Meds
Make a commentBy Ed Silverman // September 13th, 2011 // 7:43 am
Novartis, A Gleevec Patent & India: Baker Explains
1 CommentBy Ed Silverman // September 7th, 2011 // 9:21 am